Search results for "Aseptic meningitis"

showing 5 items of 5 documents

Early entry events in Echovirus 30 infection

2020

Echovirus 30 (E30), a member of the enterovirus B species, is a major cause of viral meningitis, targeting children and adults alike. While it is a frequently isolated enterovirus and the cause of several outbreaks all over the world, surprisingly little is known regarding its entry and replication strategy within cells. In this study, we used E30 strain Bastianni (E30B) generated from an infectious cDNA clone in order to study early entry events during infection in human RD cells. E30B required the newly discovered Fc echovirus receptor (FcRn) for successful infection, but not the coxsackievirus and adenovirus receptor (CAR) or decay-accelerating factor (DAF), although an interaction with …

EchovirusvirusesReceptors FcVirus Replicationmedicine.disease_causeDisease OutbreaksPhylogenyEnterovirus0303 health sciencesbiologyenterovirusechovirusEnterovirus B HumanVirus-Cell InteractionsenteroviruksetCapsidaivokalvotulehdusRNA ViralECHO-viruksetEndosomeImmunologyEchovirus InfectionsCHO CellsCoxsackievirusMicrobiologyClathrininfektiotVirusCell Line03 medical and health sciencesCricetulusVirologyEnterovirus InfectionsViral meningitismedicineAnimalsHumans030304 developmental biologyearly entry030306 microbiologySequence Analysis DNAVirus Internalizationmedicine.diseasebiology.organism_classificationVirologyaseptic meningitisA549 CellsInsect Sciencebiology.proteinEnterovirus
researchProduct

2019

Abstract Type B Coxsackieviruses (CVBs) are a common cause of acute and chronic myocarditis, dilated cardiomyopathy and aseptic meningitis. However, no CVB-vaccines are available for human use. We have previously produced virus-like particles (VLPs) for CVB3 with a baculovirus-insect cell production system. Here we have explored the potential of a VLP-based vaccine targeting CVB1 and describe the production of CVB1-VLPs with a scalable VLP purification method. The developed purification method consisting of tangential flow filtration and ion exchange chromatography is compatible with industrial scale production. CVB1-VLP vaccine was treated with UV-C or formalin to study whether stability a…

0301 basic medicinePharmacologybiologyChemistryvirusesImmunogenicity030106 microbiologyCellIndustrial scalevirus diseasesAseptic meningitisAntibody levelCoxsackievirusmedicine.diseasebiology.organism_classificationcomplex mixturesVirology3. Good health03 medical and health sciences030104 developmental biologyAntibody responsemedicine.anatomical_structureVirus-like particleVirologymedicineAntiviral Research
researchProduct

2020

Coxsackievirus B (CVB) enteroviruses are common human pathogens known to cause severe diseases including myocarditis, chronic dilated cardiomyopathy, and aseptic meningitis. CVBs are also hypothesized to be a causal factor in type 1 diabetes. Vaccines against CVBs are not currently available, and here we describe the generation and preclinical testing of a novel hexavalent vaccine targeting the six known CVB serotypes. We show that the vaccine has an excellent safety profile in murine models and nonhuman primates and that it induces strong neutralizing antibody responses to the six serotypes in both species without an adjuvant. We also demonstrate that the vaccine provides immunity against …

Serotype0303 health sciencesMultidisciplinaryMyocarditisbiologybusiness.industrymedicine.medical_treatmentImmunogenicityAseptic meningitisCoxsackievirusmedicine.diseasebiology.organism_classificationVirology03 medical and health sciences0302 clinical medicineImmunitymedicinebiology.protein030212 general & internal medicinebusinessNeutralizing antibodyAdjuvant030304 developmental biologyScience Advances
researchProduct

Meningitis bei 154 Kindern einer Kinderklinik in Deutschland: Klinische und epidemiologische Aspekte

1992

In a retrospective study, the histories of the non-neonates treated for primary meningitis in the Pediatric Department of Mainz University Hospital between 1986 and 1989 were analyzed with regard to etiological, diagnostic, clinical and epidemiological criteria. In the period studied there were 37 cases of infectious meningitis (11 Neisseria meningitidis (29.7%), 7 H. influenzae (18.9%), 3 S. pneumoniae (8.1%), 16 other (43.2%)), and 117 cases of acute aseptic meningitis syndrome (12 mumps virus (10.3%), 3 Borrelia burgdorferi (7.7%), 3 FSME (2.6%), 2 herpes simplex virus, 91 other (77.8%)). Sixty-six percent of the patients were male. Of the infants with infectious meningitis, 68% were und…

Pediatricsmedicine.medical_specialtymedicine.diagnostic_testbusiness.industryLumbar punctureNeisseria meningitidisAseptic meningitisMumps virusmedicine.disease_causemedicine.diseaseInfectious disease (medical specialty)Pediatrics Perinatology and Child HealthEpidemiologymedicineEtiologybusinessMeningitisKlinische Pädiatrie
researchProduct

Klinische Manifestation der Lyme-Borreliose im Kindesalter

1989

We report on 4 children with different clinical manifestations of Lyme-Borreliosis. One patient presented with a stage 2 typical aseptic meningitis and 2 others with symptoms of Schonlein-Henoch purpura and rheumatic disease respectively. A further case had bilateral palsy of abducens nerve and unilateral palsy of trochlearis nerve which are described for the first time in Lyme-Borreliosis. Diagnosis was established by detection of specific antibodies to Borrelia in all patients. Differential diagnosis of these symptoms should include Lyme-Borreliosis.

Pediatricsmedicine.medical_specialtyPalsybiologybusiness.industryAseptic meningitisbacterial infections and mycosesmedicine.diseasebiology.organism_classificationPurpuraLyme diseaseBorreliaPediatrics Perinatology and Child HealthMedicineDifferential diagnosisStage (cooking)medicine.symptombusinessAbducens nerveKlinische Pädiatrie
researchProduct